IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,568,000 | +785.9% | 94,200 | +756.4% | 0.01% | +550.0% |
| Q2 2017 | $177,000 | -81.5% | 11,000 | -85.4% | 0.00% | -50.0% |
| Q1 2017 | $956,000 | -75.4% | 75,600 | -74.2% | 0.00% | -91.5% |
| Q4 2016 | $3,884,000 | -20.6% | 293,100 | +42.0% | 0.05% | -11.3% |
| Q3 2016 | $4,892,000 | -3.7% | 206,400 | +17.1% | 0.05% | -7.0% |
| Q2 2016 | $5,078,000 | -1.7% | 176,200 | +9.2% | 0.06% | -1.7% |
| Q1 2016 | $5,165,000 | -37.2% | 161,300 | -16.1% | 0.06% | -45.8% |
| Q4 2015 | $8,223,000 | – | 192,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |